# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001159036-24-000007
Filing Date
2024-02-20
Accepted
2024-02-20 16:03:54
Documents
17
Period of Report
2024-02-20
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | halo-20240220.htm iXBRL | 8-K | 33569
2 | EX-99.1 | ex991q420238-k.htm | EX-99.1 | 239040
6 | GRAPHIC | halo-20240220_g1.jpg | GRAPHIC | 15840
7 | GRAPHIC | halozymea23.jpg | GRAPHIC | 701236
| Complete submission text file | 0001159036-24-000007.txt |  | 1392455

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | halo-20240220.xsd | EX-101.SCH | 1917
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | halo-20240220_lab.xml | EX-101.LAB | 24139
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | halo-20240220_pre.xml | EX-101.PRE | 12522
18 | EXTRACTED XBRL INSTANCE DOCUMENT | halo-20240220_htm.xml | XML | 2712

Mailing Address 12390 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12390 EL CAMINO REAL SAN DIEGO CA 92130 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Filer) CIK: 0001159036 (see all company filings)

EIN.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32335 | Film No.: 24653161
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)